564 filings
Page 4 of 29
SC 13D/A
OCX
Oncocyte Corporation
7 Apr 23
Oncocyte / BROADWOOD PARTNERS ownership change
10:38am
8-K
OCX
Oncocyte Corporation
6 Apr 23
Entry into a Material Definitive Agreement
5:25pm
4
Bradsher Neal C
5 Apr 23
Oncocyte / NEAL C BRADSHER ownership change
9:35pm
4
John Peter Gutfreund
5 Apr 23
Oncocyte / John Peter Gutfreund ownership change
9:30pm
4
OCX
Oncocyte Corporation
5 Apr 23
Oncocyte / Andrew Arno ownership change
9:29pm
424B5
OCX
Oncocyte Corporation
5 Apr 23
Prospectus supplement for primary offering
9:07pm
8-K
OCX
Oncocyte Corporation
5 Apr 23
Results of Operations and Financial Condition
9:00am
NT 10-K
OCX
Oncocyte Corporation
31 Mar 23
Notice of late annual filing
6:02pm
8-K
OCX
Oncocyte Corporation
31 Mar 23
ONCOCYTE REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS and PLANS TO FILE FORM 12b-25 to extend filing date of its form 10-k
5:28pm
4
Efrem Kamen
8 Mar 23
Oncocyte / Efrem Kamen ownership change
8:54pm
8-K
OCX
Oncocyte Corporation
2 Mar 23
Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer
9:05am
4
Josh Riggs
28 Feb 23
Oncocyte / Josh Riggs ownership change
5:59pm
4
Anish M. John
28 Feb 23
Oncocyte / Anish M. John ownership change
5:55pm
8-K
OCX
Oncocyte Corporation
23 Feb 23
Entry into a Material Definitive Agreement
5:00pm
8-K/A
OCX
Oncocyte Corporation
17 Feb 23
Submission of Matters to a Vote of Security Holders
4:08pm
SC 13G/A
OCX
Oncocyte Corporation
14 Feb 23
Oncocyte / PURA VIDA INVESTMENTS ownership change
1:11pm
SC 13G
OCX
Oncocyte Corporation
14 Feb 23
Oncocyte / PURA VIDA INVESTMENTS ownership change
11:33am
SC 13G
AWM Investment Company, Inc.
14 Feb 23
Oncocyte / AWM Investment ownership change
11:23am
8-K
OCX
Oncocyte Corporation
13 Feb 23
Entry into a Material Definitive Agreement
4:07pm
8-K
OCX
Oncocyte Corporation
3 Feb 23
Entry into a Material Definitive Agreement
4:05pm